Abstract:Peroxiredoxin‐4 (PRDX4), an endoplasmic reticulum (ER)‐localized antioxidant enzyme, plays an essential role in cellular redox homeostasis by reducing hydrogen peroxide from thiol‐containing compounds. The dopamine D5 Receptor (D5R) also plays a protective role against oxidative stress. We hypothesize that D5R interacts with the PRDX4 to reduce oxidative stress in the kidney. In D5R‐HEK 293 cells, fenoldopam (FEN, 25 nM/12 hr, n=4), a D1R and D5R receptor agonist, increased PRDX4 protein expression (1.92±0.12‐fold over basal level, n=4), mainly in non‐lipid raft (LR) fractions (LRs: 24.9±11.4%, non‐LRs: 75.1±11.4%, baseline; LRs: 30.9±13.9%, non‐LRs: 174.1±16.7%, FEN). By contrast, fenoldopam did not affect PRDX4 protein expression in D1R‐HEK 293 cells, indicating a D5R‐specific effect on PRDX4 protein expression. In human renal proximal tubule cells (hRPTCs) and D5R HEK293 cells, fenoldopam increased the co‐immunoprecipitation between PRDX4 and D5R and their co‐localization in the ER. SiRNA‐mediated silencing of PRDX4 increased hydrogen peroxide production in both the vehicle (Veh)‐ and fenoldopam‐treated hRPTCs [(scrambled siRNA: 100 ±15.1% and 55.2± 7.2% with Veh and FEN, respectively; PRDX4 siRNA: 161.8±15.3% and 145.1±14.6 % with Veh and FEN, respectively, n=4)]. The D5R protects against inflammation and siRNA silencing of PRDX4 increased the production of the pro‐inflammatory cytokines, interleukin‐1β [26.88±3.8 and 46.40±4.2 pg/mL (n=3, D5R‐HEK 293); 15.87±1.2 and 37.9±1.4 pg/mL (n=3, hRPTCs), and tumor necrosis factors [131.7±6.5 and 271.2±18.1 pg/mL (n=4, D5R‐HEK 293); 108.8±11.8 and 240.1±13.7 pg/mL (n=4, hRPTCs)]. In D5R‐HEK293 and hRPTCs, the fenoldopam‐mediated decrease in ER‐resident caspase‐12 was also impaired by gene silencing of PRDX4. Furthermore, PRDX4 protein expression was reduced in the kidney cortices of Drd5‐/‐ mice, relative to Drd5 WT mice (WT: 1.00±0.12, n=4; Drd5‐/‐: 0.64±0.13, n=4; P<0.05). We conclude that D5R positively interacts with PRDX4 to reduce ER stress in the kidney.

Protective Effects Of Peroxiredoxin 4 (Prdx4) On Cholestatic Liver Injury

The Association of Peroxiredoxin 4 with the Initiation and Progression of Hepatocellular Carcinoma

Peroxiredoxin 4 (PRDX4): Its critical in vivo roles in animal models of metabolic syndrome ranging from atherosclerosis to nonalcoholic fatty liver disease

Overexpression of Peroxiredoxin 4 Affects Intestinal Function in a Dietary Mouse Model of Nonalcoholic Fatty Liver Disease

Overexpression of Peroxiredoxin 4 Attenuates Atherosclerosis in Apolipoprotein E Knockout Mice.

Peroxiredoxin 4 Protects Against Nonalcoholic Steatohepatitis and Type 2 Diabetes in a Nongenetic Mouse Model.

Overexpression of peroxiredoxin 4 protects against high-dose streptozotocin-induced diabetes by suppressing oxidative stress and cytokines in transgenic mice.

Peroxiredoxins in inflammatory liver diseases and ischemic/reperfusion injury in liver transplantation.

Peroxiredoxin 4 suppresses anoikis and augments growth and metastasis of hepatocellular carcinoma cells through the β-catenin/ID2 pathway

Hepatocytes-derived Prdx1 regulates macrophage phenotypes via TLR4 activation in acute liver injury

Peroxiredoxin 6 attenuates ischemia- and hypoxia-induced liver damage of brain-dead donors

Loss of Peroxiredoxin IV Protects Mice from Azoxymethane/Dextran Sulfate Sodium-Induced Colorectal Cancer Development

Overexpression Of Prdx4 Modulates Tumor Microenvironment And Promotes Urethane-Induced Lung Tumorigenesis

Transgenic overexpression of peroxiredoxin-2 attenuates ischemic neuronal injury via suppression of a redox-sensitive pro-death signaling pathway.

Peroxiredoxin-1 Attenuates Hepatic Fibrosis By Inhibiting Tgf-Beta 1/Smad3 And Ros Signal Pathways

PRDX6 inhibits hepatic stellate cells activation and fibrosis via promoting MANF secretion

Double Knockout of Peroxiredoxin 4 (Prdx4) and Superoxide Dismutase 1 (Sod1) in Mice Results in Severe Liver Failure

Both Peroxidase and Phospholipase A2 Activities of peroxiredoxin 6 Protect Against Oxidative Stress by Reduction of Peroxidized Cell Membranes

Peroxiredoxin 4 protects against ovarian ageing by ameliorating D-galactose-induced oxidative damage in mice

Peroxiredoxin‐4 Interacts with Dopamine D5 Receptor to Reduce Endoplasmic Reticulum Stress

Critical role of peroxiredoxin 6 in the repair of peroxidized cell membranes following oxidative stress